4.7 Article

Age at onset in two common neurodegenerative diseases is genetically controlled

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 70, Issue 4, Pages 985-993

Publisher

CELL PRESS
DOI: 10.1086/339815

Keywords

-

Funding

  1. NCRR NIH HHS [M01 RR 00865, M01 RR000865] Funding Source: Medline
  2. NIA NIH HHS [P30 AG010123, AG 11268, U24 AG021886, P50 AG005128, AG 10123, P50 AG 05128, AG 13308, P60 AG011268, R01 AG013308] Funding Source: Medline
  3. NIMH NIH HHS [R01 MH052453, MH 52453] Funding Source: Medline
  4. NINDS NIH HHS [P50 NS039764, R01 NS031153, P01 NS 26630, NS 31153, P50 NS 39764, P01 NS026630] Funding Source: Medline

Ask authors/readers for more resources

To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, a genomic screen was performed for AAO in families with Alzheimer disease (AD; n = 449) and Parkinson disease (PD; n = 174). Heritabilities between 40%- 60% were found in both the AD and PD data sets. For PD, significant evidence for linkage to AAO was found on chromosome 1p (LOD = 3.41). For AD, the AAO effect of APOE (LOD = 3.28) was confirmed. In addition, evidence for AAO linkage on chromosomes 6 and 10 was identified independently in both the AD and PD data sets. Subsequent unified analyses of these regions identified a single peak on chromosome 10q between D10S1239 and D10S1237, with a maximum LOD score of 2.62. These data suggest that a common gene affects AAO in these two common complex neurodegenerative diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available